Identification of Antineoplastic Targets with Systems Approaches, Using Resveratrol as an In-Depth Case Study

Nivedita Singh1, Sherry Freiesleben2, Olaf Wolkenhauer2

  • 1CSIR-Indian Institute of Toxicology Research, Lucknow, Uttar Pradesh. India.

Insights

This review explores systems approaches for integrating multi-omics data to discover novel anticancer drug-target combinations. A case study on resveratrol highlights network analysis for understanding its mechanisms in cancer.

Area of Science:

  • Computational biology
  • Pharmacology
  • Oncology

Background:

  • Drug discovery relies on identifying effective drug-target combinations.
  • Cancer's complexity necessitates integrating multi-omics data for better treatment strategies.
  • Challenges exist in combining diverse data for anticancer drug development, balancing efficacy and toxicity.

Purpose of the Study:

  • To review systems approaches for integrating multi-omics data in drug discovery.
  • To investigate anticancer mechanisms and targets of resveratrol using network analysis.
  • To demonstrate the utility of systems approaches for understanding small molecule-target interactions.

Main Methods:

  • Review of systems biology approaches for data integration.
  • Network analysis to study biological mechanisms.
  • Reverse pharmacophore mapping as a case study for resveratrol.

Main Results:

  • Systems approaches facilitate the integration of various data types for drug discovery.
  • Network analysis provides mechanistic insights into resveratrol's anticancer effects.
  • Reverse pharmacophore mapping aids in understanding small molecule binding to targets.

Conclusions:

  • Systems approaches are crucial for advancing anticancer drug discovery.
  • Network analysis offers a powerful tool for hypothesis generation and mechanistic understanding.
  • Resveratrol's anticancer properties can be further elucidated through these computational methods.

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
49
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
51
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K